IP Verse

Lipopeptide Compositions And Related Methods - EP2504353

The patent EP2504353 was granted to Cubist Pharmaceuticals on Sep 13, 2023. The application was originally filed on Nov 23, 2010 under application number EP10832379A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2504353

CUBIST PHARMACEUTICALS
Application Number
EP10832379A
Filing Date
Nov 23, 2010
Status
Patent Maintained As Amended
Aug 11, 2023
Grant Date
Sep 13, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PAJAROApr 11, 2019BIRD & BIRDADMISSIBLE
HGFApr 10, 2019DENTONS UK AND MIDDLE EASTADMISSIBLE

Patent Citations (26) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2002111311
DESCRIPTIONUS2007116729
DESCRIPTIONUS2009197799
DESCRIPTIONUS4874843
DESCRIPTIONUS6696412
DESCRIPTIONWO0153330
DESCRIPTIONWO2009144739
EXAMINATIONCN1616083
EXAMINATIONEP0386951
INTERNATIONAL-SEARCH-REPORTUS2002111311
INTERNATIONAL-SEARCH-REPORTUS2007116729
INTERNATIONAL-SEARCH-REPORTUS2009197799
INTERNATIONAL-SEARCH-REPORTWO0153330
OPPOSITIONEP0386951
OPPOSITIONEP2504353
OPPOSITIONUS2005027113
OPPOSITIONUS2006029599
OPPOSITIONUS5952300
OPPOSITIONWO0153330
OPPOSITIONWO2007061529
OPPOSITIONWO2008012310
OPPOSITIONWO2009002481
OPPOSITIONWO2011062676
OPPOSITIONWO2011063419
SEARCHUS4874843
SEARCHWO2009144739

Non-Patent Literature (NPL) Citations (15) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BALTZ, Biotechnology of Antibiotics, MARCEL DEKKER, INC., (1997), pages 415 - 435-
DESCRIPTION- DEBONO ET AL., THE JOURNAL OF ANTIBIOTICS, (1988), vol. 41, no. 8, page 1093-
DESCRIPTION- KIRSCH ET AL., PHARMACEUTICAL RESEARCH, (1989), vol. 6, pages 387 - 393-
DESCRIPTION- MIAO, MICROBIOLOGY, (2005), vol. 151, no. 5, page 1507-
OPPOSITION- CARPENTER et al., "Rational Design of Stable Lyophilized Protein Formulations: Theory and Practice", CARPENTER et al., Carpenter et al, Rational Design of stable protein formulations, New York, (20020000), pages 109 - 133, XP009053337-
OPPOSITION- "Cubicin®", (20070300), pages 1 - 28, XP055582591-
OPPOSITION- NAIL et al., "FUNDAMENTALS OF FREEZE-DRYING", Pharmaceutical Biotechnology, (20020200), vol. 14, pages 281 - 360, XP001181137-
OPPOSITION- "pH", Wikipedia, (20091119), URL: https://en.wikipedia.org/w/index.php?title=PH&oldid=326684718, XP055582615-
OPPOSITION- "pH", Wikipedia, (20190331), URL: https://en.wikipedia.org/w/index.php?title=PH&oldid=890251285, XP055582627-
OPPOSITION- MUANGSIRI et al., "The kinetics of the Alkaline Degradation of Daptomycin", Journal of Pharmaceutical Sciences, (20010800), vol. 90, no. 8, pages 1066 - 1075, XP008161425
OPPOSITION- WANG, "Lyophilization and development of solid protein pharmaceuticals", International Journal of Pharmaceutics, (20000828), vol. 203, no. 1-2, pages 1 - 60, XP002428586
OPPOSITION- FRANKS, "Freeze-drying of bioproducts: putting principles into practice", European Journal of Pharmaceutics and Biopharmaceutics, (19980000), vol. 45, no. 3, pages 221 - 229, XP000751942
OPPOSITION- CARPENTER et al., "Rational design of stable lyophilized protein formulations: Some practical advice", Pharmaceutical Research, (19970800), vol. 14, no. 8, pages 969 - 975, XP002303280
SEARCH- V. MIAO, "Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry", MICROBIOLOGY, (20050501), vol. 151, no. 5, doi:10.1099/mic.0.27757-0, ISSN 1350-0872, pages 1507 - 1523, XP055103297 [X] 1,2,8-10 * page 1509, column 2 *
SEARCH- MANUEL DEBONO ET AL, "THE JOURNAL OF ANTIBIOTICS ENZYMATIC AND CHEMICAL MODIFICATIONS OF LIPOPEPTIDE ANTIBIOTIC A21978C : THE SYNTHESIS AND EVALUATION OF DAPTOMYCIN (LY146032)", THE JOURNAL OF ANTIBIOTICS, (19880801), vol. 41, no. 8, doi:http://dx.doi.org/10.7164/antibiotics.41.1093, ISSN 0021-8820, pages 1193 - 1105, XP055103295 [X] 1,2,8-10 * page 1103 - page 1104 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents